Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis

Rheumatology (Oxford). 2024 Jan 4;63(1):103-110. doi: 10.1093/rheumatology/kead164.

Abstract

Objective: Stratifying the risk of death in SSc-related interstitial lung disease (SSc-ILD) is a challenging issue. The extent of lung fibrosis on high-resolution CT (HRCT) is often assessed by a visual semiquantitative method that lacks reliability. We aimed to assess the potential prognostic value of a deep-learning-based algorithm enabling automated quantification of ILD on HRCT in patients with SSc.

Methods: We correlated the extent of ILD with the occurrence of death during follow-up, and evaluated the additional value of ILD extent in predicting death based on a prognostic model including well-known risk factors in SSc.

Results: We included 318 patients with SSc, among whom 196 had ILD; the median follow-up was 94 months (interquartile range 73-111). The mortality rate was 1.6% at 2 years and 26.3% at 10 years. For each 1% increase in the baseline ILD extent (up to 30% of the lung), the risk of death at 10 years was increased by 4% (hazard ratio 1.04, 95% CI 1.01, 1.07, P = 0.004). We constructed a risk prediction model that showed good discrimination for 10-year mortality (c index 0.789). Adding the automated quantification of ILD significantly improved the model for 10-year survival prediction (P = 0.007). Its discrimination was only marginally improved, but it improved prediction of 2-year mortality (difference in time-dependent area under the curve 0.043, 95% CI 0.002, 0.084, P = 0.040).

Conclusion: The deep-learning-based, computer-aided quantification of ILD extent on HRCT provides an effective tool for risk stratification in SSc. It might help identify patients at short-term risk of death.

Keywords: SSc; artificial intelligence; high-resolution CT; interstitial lung disease; prognosis.

MeSH terms

  • Humans
  • Lung
  • Lung Diseases, Interstitial* / diagnostic imaging
  • Lung Diseases, Interstitial* / epidemiology
  • Lung Diseases, Interstitial* / etiology
  • Prognosis
  • Reproducibility of Results
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / diagnostic imaging
  • Tomography, X-Ray Computed
  • Vital Capacity